DCM Precision Medicine Study
Trial ID or NCT#
Status
Purpose
The aims of the DCM Precision Medicine Study are to test the hypothesis that DCM has substantial genetic basis and to evaluate the effectiveness of a family communication intervention in improving the uptake and impact of family member clinical screening.
Official Title
Precision Medicine for Dilated Cardiomyopathy in European and African Ancestry
Eligibility Criteria
- * Meeting criteria for dilated cardiomyopathy (DCM) :
- * Left ventricular ejection fraction \<50% * Left ventricular enlargement (A left ventricular end-diastolic dimension \> 95%tile population standard based on gender and height).* Detectable causes of cardiomyopathy, except genetic, excluded beyond a reasonable doubt at the time of DCM diagnosis (that is, meeting clinical criteria for idiopathic DCM)* Any age (including children)* Non-Hispanic and Hispanic ethnicity* All races (PI pre-approval required for recruitment beyond pre-specified recruitment targets).* Ability to give informed consent* Ability to communicate in English (except Spanish language at sites approved to recruit individuals of Hispanic ethnicity)* Willingness to participate in a family-based study (patient willing to work with a clinical site and/or OSU to facilitate the recruitment and enrollment of family members to the study).
- * Coronary artery disease (CAD) causing ischemic cardiomyopathy (\> 50% narrowing, any major epicardial coronary artery)* Primary valvular disease* Adriamycin or other cardiotoxic drug exposure* Other forms of cardiomyopathy: Hypertrophic, Restrictive, or Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy* Congenital heart disease* Other detectable causes of dilated cardiomyopathy, including sarcoid and hemochromatosis.* Other active multi-system disease that may cause DCM (e.g., active connective tissue disease).* Severe and untreated or untreatable hypertension (systolic blood pressures routinely greater than 180 mm Hg and/or diastolic blood pressures greater than 120 mm Hg, and if resistant to multidrug treatment).* However, conventional risk factors for DCM, including obesity, routinely treated hypertension, alcohol use, pregnancy or the peri-partum period, or left ventricular noncompaction, will NOT be considered exclusion criteria.
Investigator(s)
Contact us to find out if this trial is right for you.
Contact
DCM Coordinators
650 725-6911
View on ClinicalTrials.gov